NRAS and cancer: To analyze whether the mutation status of the NRAS oncogene can serve as biomarker for responsiveness to NRAS-mRNA targeting therapy, we analyzed NRAS-mRNA knockdown effects in human cell lines, using the Cancer Dependency Map portal (https://depmap.org/portal/).